Kilitch Drugs commences nutraceutical production at Raigad facility

Kilitch Drugs has commenced nutraceutical manufacturing at its new plant located in Village Maldev, Taluka Pen, District Raigad, Maharashtra on June 17, 2026. This operational expansion marks a significant milestone in the company's strategy to scale its presence in the nutraceutical segment.

Facility Details

The new manufacturing block is situated in the Raigad district of Maharashtra. The following table outlines the key parameters of the development:

Parameter	Details
Company	Kilitch Drugs
Activity	Commencement of Nutraceutical Production
Facility Location	Village: Maldev, Taluka: Pen, District: Raigad, Maharashtra
Product Type	Nutraceuticals

Strategic Expansion

The commissioning of the Maldev facility represents a direct expansion of Kilitch Drugs' manufacturing capabilities. By establishing this new production block, the company aims to leverage the growing demand for nutraceutical products in India. This move underscores the company's commitment to enhancing its footprint in this specific category.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.14%	-2.92%	+18.14%	-46.14%	-59.12%	+17.43%

kilitch drugs has confirmed that its promoters and promoter group have not created any encumbrance over the shares held by them during the financial year ended March 31, 2026. The disclosure was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011.

The company submitted the declaration to both BSE Limited and the National Stock Exchange of India Ltd (NSE) on April 4, 2026. The confirmation covers shares held directly or indirectly by the promoters and persons acting in concert with them.

Key Details of the Disclosure

Particulars	Details
Regulation	Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011
Financial Year	Year ended March 31, 2026
Encumbrance Status	No encumbrance over shares held by promoters and promoter group
Date of Disclosure	April 4, 2026

The declaration was signed by Mukund Mehta, Managing Director and Promoter of Kilitch Drugs (India) Limited, on behalf of all the promoters and the promoter group. Copies of the communication were also forwarded to the Company Secretary and the Audit Committee of the company.